Trends in Pharmacological Sciences Submission Guide

Source: Clarivate 2026 JCR release, Cell Press editorial disclosures (accessed April 2026).

Source: TIPS author guidelines.

Use this page when deciding:

• whether the proposed Review has a synthesis argument

• whether the author team has pharmacology authority

• whether topic timing is right

• a clear synthesis argument

• author authority with primary-research evidence

• topic-timing case

• direct pharmacology contribution

• a 1-2 page outline

• Topic recently covered in TIPS.

• Author standing in adjacent rather than central pharmacology.

• Scope framed as comprehensive survey rather than synthesis.

• Pharmacology relevance is peripheral.

TIPS is among the highest-impact pharmacology journals.

Trends-style standard: the journal differentiates from Pharmacological Reviews (Annual-Review-style) and Drug Discovery Today (broader applied) by demanding Trends-style forward-looking synthesis.

Authority expectation: editors weigh sustained primary-research records.

Long planning horizon: invitations often planned 12-18 months ahead.

The strongest TIPS inquiry letters establish:

• the synthesis argument

• the author authority

• the topic-timing case

• the pharmacology relevance

• the synthesis argument is clear

• the author team has primary-research record

• the topic-timing case is strong

• pharmacology relevance is direct

• Is Trends in Pharmacological Sciences a good journal?

Before contacting, run your proposal through a TIPS presubmission readiness check.

Read the public instructions for mechanics, then pressure-test the package the way an editor will see it. The review tells you whether your paper clears the Trends in Pharmacological Sciences fit check before upload, especially around comprehensive-survey framing without synthesis argument, topic-timing collision with recent TIPS coverage, and author standing in adjacent rather than central pharmacology. Paid Manusights reviews include a 60-day money-back guarantee, and we do not train models on submitted manuscripts.

Across Manusights submission reviews for Review proposals targeting TIPS, three patterns generate the most consistent inquiry declines.

In our pre-submission review work we see many TIPS declines trace to comprehensive-survey framing. We often find these cases involve topic-timing collision. A related pattern is that these cases often arise from author-authority gaps.

Comprehensive-survey framing without synthesis argument

TIPS editors look for organizing argument or contrarian thesis. We observe inquiries framed as "comprehensive review of [topic]" routinely declined.

Check comprehensive survey framing without synthesis argument before submitting to Trends in Pharmacological Sciences →

Topic-timing collision with recent TIPS coverage

TIPS editors check the journal's recent issues. We see inquiries on topics covered within 3-5 years routinely declined unless a clearly distinct angle is articulated.

Check topic timing collision with recent tips coverage before submitting to Trends in Pharmacological Sciences →

Author standing in adjacent rather than central pharmacology

TIPS editors weigh authority heavily. We find inquiries from authors with primary research in adjacent fields routinely declined unless the pharmacology connection is direct. A TIPS presubmission readiness check can identify whether the inquiry case is strong.

Clarivate 2026 JCR release bibliometric data places TIPS among top pharmacology journals.

Check author standing in adjacent rather than central pharmacology before submitting to Trends in Pharmacological Sciences →

Before the reviewer-invitation stage, read the Trends in Pharmacological Sciences package against the same risks this guide flags in the Manusights section. The practical question is whether the abstract, cover letter, figures or tables, methods, reporting statements, supplementary files, and references all make the journal choice obvious.

• If the abstract still points toward comprehensive-survey framing without synthesis argument, revise the central claim before upload.

• If the evidence package leaves topic-timing collision with recent TIPS coverage, strengthen the methods, controls, figures, or supplementary material rather than expecting reviewers to infer it.

• If the cover letter cannot resolve author standing in adjacent rather than central pharmacology, compare the target journal against the adjacent venues named above before submitting.

In pre-inquiry diagnostic work for top Trends-style pharmacology journals, we consistently see four signals that distinguish strong proposals from weak ones. First, the proposed topic must align with what TIPS editors are publicly signaling as priority directions. Second, the author CV should show 10+ primary-research papers in the exact pharmacology subfield. Third, the proposal should differentiate sharply from Reviews published in TIPS in the prior 5 years. Fourth, the proposal should be framed around a synthesis argument.

For Trends In Pharmacological Sciences-targeted manuscripts, beyond the rubric checks, three pre-inquiry diagnostic patterns recur most often in the proposals we review for TIPS. First, contact letters that begin with topic-context paragraphs rather than the synthesis argument lose force in editorial scanning. Second, contacts where the author authority section uses generic language are flagged for authority concerns. Third, contacts that lack engagement with TIPS's recent issues are at risk of being told the proposal doesn't fit the publication conversation.

For Trends In Pharmacological Sciences-targeted manuscripts, the strongest proposals we coach distinguish themselves on three operational behaviors. First, they confine the inquiry letter to one page and use it to make the case for fit, contribution, and significance. Second, they include a one-sentence elevator pitch in the inquiry's opening that the editor can use when discussing the proposal internally. Third, they identify the specific recent TIPS articles that this proposal builds on and the specific gap the Review will address.